1 Min Read
Nov 10 (Reuters) - Cadila Healthcare Ltd
* Zydus gets marketing approval from Mexico regulatory authority to commercialize lipaglyn (saroglitazar magnesium) Source text - bit.ly/2hZI4W9 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.